U.S. Markets open in 35 hrs, 10 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,220.96 | 32.73 | 0.29% |
| NASDAQ | 2,255.88 | -3.16 | -0.14% |
| S&P 500 | 1,242.31 | 5.48 | 0.44% |
| Date | Time(ET) | Upcoming Events | Set Alert |
|---|---|---|---|
| 09/22/2008 | 22:00 | ALEXZA PHARMACEUTICALS INC at UBS Global Life Sciences Conference |  |
| Date | Previous Event | Listen | Transcript/Brief |
|---|---|---|---|
| 09/04/2008 | Alexza Pharmaceuticals Inc. at NewsMakers in the Biotech Industry | — | — |
| 09/03/2008 | ALEXZA PHARMACEUTICALS INC Conference Call |  |
— |
| 08/07/2008 | Q2 2008 ALEXZA PHARMACEUTICALS INC Earnings Conference Call | |
— |
| 08/06/2008 | Q2 2008 ALEXZA PHARMACEUTICALS INC Earnings Release | — | — |
| 06/25/2008 | ALEXZA PHARMACEUTICALS INC at Piper Jaffray Europe Conference | |
— |
| 06/09/2008 | ALEXZA PHARMACEUTICALS INC Conference Call to Announce the Completion of Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation | — | — |
| 05/21/2008 | ALEXZA PHARMACEUTICALS INC at Citigroup Healthcare Conference | — | — |
| 05/19/2008 | ALEXZA PHARMACEUTICALS INC at JMP Securities Research Conference | — | — |
| 05/12/2008 | Q1 2008 ALEXZA PHARMACEUTICALS INC Earnings Conference Call | |
Download($) |
| 05/12/2008 | Q1 2008 ALEXZA PHARMACEUTICALS INC Earnings Release | — | — |
| Date/Time (ET) | Period | EPS Estimate | EPS Actual | Prev Year Actual | |
|---|---|---|---|---|---|
| 06/30/08 | Q2 2008 | $-0.468 | $-0.43 | $-0.36 | |
| 03/31/08 | Q1 2008 | $-0.39 | $-0.47 | $-0.46 | |
| 12/31/07 | Q4 2007 | $-0.363 | $-0.42 | $-0.49 | |
| 09/30/07 | Q3 2007 | $-0.364 | $-0.35 | $-0.47 |
| BMO: Before Market Opens |
| AMC: After Market Closes |
| There are no splits available. |
| Payable | Amount/Share | Ex-Date | Record | Declaration | |
|---|---|---|---|---|---|
| — | $0.00 | — | — | 12/25/2007 | |
| — | $0.00 | — | — | 09/25/2007 | |
| — | $0.00 | — | — | 06/25/2007 | |
| — | $0.00 | — | — | 03/25/2007 |
